Funding the Final Mile of Engineering & Clinical Validation

​

​

The AMVC Blood Collection System is a fully patented, lab-compatible platform with the potential to transform diagnostics—but to bring it to market, we need strategic funding to complete engineering refinement and clinical validation. This next phase includes finalizing device integration, executing hospital-based studies, and generating the clinical evidence required for FDA submission and adoption.

 

With the right investment, we can close the gap between innovation and impact—delivering cleaner samples, safer workflows, and better outcomes at scale.

 

​

​

Ready to rethink blood collection? Let’s connect.​

​​